Indication

OPTISON

1 clinical trial

1 product

Clinical trial

A Phase 4, Open-Label, Non-randomized, Multicenter Study to Evaluate Safety and Efficacy of Intravenous Administration of OPTISON™ for Contrast- Enhanced Echocardiography in Pediatric Patients

Status: Completed, Estimated PCD: 2023-03-30

Product